Anticoagulant Therapy for 6 Weeks vs 3 Months and Recurrence and Bleeding in Patients Younger Than 21 Years With Provoked Venous Thromboembolism-Reply

JAMA. 2022 May 3;327(17):1709-1710. doi: 10.1001/jama.2022.3729.

Authors

Neil A Goldenberg¹, Leonardo R Brandão², Christoph Male³; Kids-DOTT Trial Investigators

Affiliations

¹ Johns Hopkins University, Johns Hopkins All Children's Institute for Clinical and Translational Research, St Petersburg, Florida.
² University of Toronto, Toronto, Ontario, Canada.
³ Medical University of Vienna, Vienna, Austria.

PMID: 35503347
DOI: 10.1001/jama.2022.3729

No abstract available

Publication types

Comparative Study
Comment

MeSH terms

Age Factors
Anticoagulants* / administration & dosage
Anticoagulants* / adverse effects
Anticoagulants* / therapeutic use
Hemorrhage* / chemically induced
Humans
Recurrence
Risk Factors
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control
Young Adult

Substances

Anticoagulants